Pembrolizumab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer

NCT06230471 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Biliary Tract Neoplasms Immunotherapy

Interventions

DRUG: Pembrolizumab,Lenvatinib and Gemox Chemotherapy（Gemcitabine and Oxaliplatin）
DRUG: Pembrolizumab and Lenvatinib
DRUG: Pembrolizumab and Gemox Chemotherapy（Gemcitabine and Oxaliplatin）

Sponsor

Peking Union Medical College Hospital